Revenue

The Shark Tank success story is betting on dessert-flavored rice cakes to capture a market that's grown 74%. Is this the future of guilt-free snacking?

A new podcast, 'Take Yourself To Work,' leverages expert insight and real-life stories to guide professionals through the modern quest for an authentic career.

Celebrating ten years with record revenue, Waterdrop Inc. doubles down on AI to fuse financial growth with a profound social mission in healthcare.

Frustrated by political gridlock, 150 Israeli and Palestinian leaders delivered a detailed peace plan to the G7, backed by major new international funding.

The platform's rapid growth signals a shift from viral fame to stable careers, as direct fan-support models empower a burgeoning 'creator middle class'.

With the hire of veteran banker Michael Sharpton and an 18-person team, American Pride Bank signals an aggressive expansion into the Carolinas and Florida.

A new league, backed by entertainment titans from WWE and Turner, aims to bring professional sumo to US arenas. But can it transform a niche sport into a mainstream success?

After a disastrous failure, Stephenville's airport has a new owner. BTG Capital's acquisition is more than a local rescue; it's a play on global trade and defence.

Leveraging nostalgia and new market data, Crayola is targeting adults with its 'All Grown Up' line. Is this a savvy pivot or a brand identity risk?

The new 'BB-' rating for EquipmentShare is more than a financial milestone. It's a validation of how its T3 tech platform is building a new giant.

VitalEdge adds former Hitachi CEO Alan Quinn to its board, a strategic move to blend deep OEM expertise with its push to dominate heavy equipment tech.

A guidance cut at Sanuwave reveals a deeper crisis in wound care, driven by CMS policy shifts that are fueling a disruptive secondary equipment market.

Eclipse Automation's new RealitySync platform lets manufacturers walk through factories before they exist. Is this just a tech demo or the future of de-risking industrial investments?

Pennymac's move to make AWS its preferred cloud isn't just a tech upgrade. It’s a calculated play to transform its core platform into a commercial asset.

A $151B contract for missile defense is about more than hardware. It signals a new era where human-machine teaming and cognitive science are the front lines.

Mophie's new chargers promise a fan-less, full-speed 25W future for Apple devices. We go beyond the launch to see if this quiet innovation can solve wireless charging's biggest heat problem.

BioAge Labs starts a Phase 2 trial for BGE-102, an oral drug targeting inflammation to reduce heart risk, a strategy that could redefine cardiovascular care.

As 2Checkout hosts its 10th annual summit, business leaders grapple with AI's rise, global compliance headaches, and the relentless pressure of a new economy.

Adial Pharmaceuticals pivots from addiction to inflammation, securing $32M and poaching Azora's leadership to drive its new ulcerative colitis drug, AT177.

Private equity firm Sagewind Capital's latest hire isn't just another suit. It's a strategic move revealing a much deeper trend in high-stakes GovTech.